Boston Scientific Shares Outstanding History (BSX)
Boston Scientific reported 1.39B shares outstanding at the end of fiscal 2019.
View full Boston Scientific company overviewBoston Scientific annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | 1.39B | 10.3M | +0.75% |
| 2018 | 2018-12-31 | 1.38B | 11.1M | +0.81% |
| 2017 | 2017-12-31 | 1.37B | 11.4M | +0.84% |
| 2016 | 2016-12-31 | 1.36B | 15.5M | +1.15% |
| 2015 | 2015-12-31 | 1.35B | 19.2M | +1.45% |
| 2014 | 2014-12-31 | 1.33B | 5.2M | +0.39% |
| 2013 | 2013-12-31 | 1.32B | −33.4M | −2.46% |
| 2012 | 2012-12-31 | 1.36B | −93.3M | −6.44% |
| 2011 | 2011-12-31 | 1.45B | −71.7M | −4.72% |
| 2010 | 2010-12-31 | 1.52B | — | — |
Boston Scientific quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q1 2020 | 2020-03-31 | 1.40B | 8.7M | +0.63% |
| Q4 2019 | 2019-12-31 | 1.39B | 10.3M | +0.75% |
| Q3 2019 | 2019-09-30 | 1.39B | 10.1M | +0.73% |
| Q2 2019 | 2019-06-30 | 1.39B | 10.2M | +0.74% |
| Q1 2019 | 2019-03-31 | 1.39B | 11.0M | +0.79% |
| Q4 2018 | 2018-12-31 | 1.38B | 11.1M | +0.81% |
| Q3 2018 | 2018-09-30 | 1.38B | 11.0M | +0.80% |
| Q2 2018 | 2018-06-30 | 1.38B | 10.8M | +0.79% |
| Q1 2018 | 2018-03-31 | 1.38B | 10.5M | +0.77% |
| Q4 2017 | 2017-12-31 | 1.37B | 11.4M | +0.84% |
| Q3 2017 | 2017-09-30 | 1.37B | 11.3M | +0.83% |
| Q2 2017 | 2017-06-30 | 1.37B | 11.8M | +0.87% |
| Q1 2017 | 2017-03-31 | 1.37B | 14.5M | +1.07% |
| Q4 2016 | 2016-12-31 | 1.36B | 15.5M | +1.15% |
| Q3 2016 | 2016-09-30 | 1.36B | 16.6M | +1.23% |
| Q2 2016 | 2016-06-30 | 1.36B | 16.5M | +1.23% |
| Q1 2016 | 2016-03-31 | 1.35B | 14.6M | +1.09% |
| Q4 2015 | 2015-12-31 | 1.35B | 19.2M | +1.45% |
| Q3 2015 | 2015-09-30 | 1.34B | 18.9M | +1.42% |
| Q2 2015 | 2015-06-30 | 1.34B | 18.4M | +1.39% |
| Q1 2015 | 2015-03-31 | 1.34B | 17.5M | +1.33% |
| Q4 2014 | 2014-12-31 | 1.33B | 5.2M | +0.39% |
| Q3 2014 | 2014-09-30 | 1.33B | −12.8M | −0.96% |
| Q2 2014 | 2014-06-30 | 1.32B | −15.6M | −1.16% |
| Q1 2014 | 2014-03-31 | 1.32B | −27.9M | −2.07% |
| Q4 2013 | 2013-12-31 | 1.32B | −33.4M | −2.46% |
| Q3 2013 | 2013-09-30 | 1.34B | −34.0M | −2.48% |
| Q2 2013 | 2013-06-30 | 1.34B | −77.2M | −5.45% |
| Q1 2013 | 2013-03-31 | 1.35B | −83.8M | −5.84% |
| Q4 2012 | 2012-12-31 | 1.36B | −93.3M | −6.44% |
| Q3 2012 | 2012-09-30 | 1.37B | −128.1M | −8.54% |
| Q2 2012 | 2012-06-30 | 1.42B | −112.3M | −7.34% |
| Q1 2012 | 2012-03-31 | 1.43B | −86.5M | −5.69% |
| Q4 2011 | 2011-12-31 | 1.45B | — | — |
| Q3 2011 | 2011-09-30 | 1.50B | — | — |
| Q2 2011 | 2011-06-30 | 1.53B | — | — |
| Q4 2010 | 2010-12-31 | 1.52B | — | — |
Boston Scientific shares outstanding trends
Over the last five reported fiscal years, Boston Scientific's shares outstanding moved from 1.33B to 1.39B, a change of 67.5M. The latest reported quarter, Q1 2020, shows 1.40B.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Boston Scientific filings at SEC.gov ↗